Show simple item record

dc.contributor.authorWorld Health Organization
dc.coverage.spatialGenève
dc.coverage.spatialGenève
dc.date.accessioned2012-06-16T14:49:32Z
dc.date.available2012-06-16T14:49:32Z
dc.date.created2007fr
dc.date.issued2007fr
dc.identifier.isbn9789242594706
dc.identifier.urihttps://iris.who.int/handle/10665/43695
dc.description"Charles Gilks et Marco Vitoria, du Département VIH/SIDA de l'Organisation mondiale de la Santé, ont assuré la coordination des travaux"--Remerciementsfr
dc.description61 p.fr
dc.language.isoenen
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéfr
dc.subject.meshTrimethoprim, Sulfamethoxazole Drug Combinationfr
dc.subject.meshAIDS-Related Opportunistic Infectionsfr
dc.subject.meshGuidelinefr
dc.subject.meshDeveloping Countriesfr
dc.subject.otherAIDS and its Controlfr
dc.titleDirectives sur l'utilisation du Cotrimoxazole pour la prophylaxie des infections liées au VIH chez l'enfant, l'adolescent et l'adulte : recommandations pour une approche de santé publiquefr
dc.title.alternativeGuidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings : recommendations for a public health approachfr
dc.subject.meshqualifieradverse effects therapeutic usefr
dc.subject.meshqualifierprevention and controlfr
who.relation.languageVersion10665/43557en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record